SCHEMBL12468290

SCHEMBL12468290

COc1ccc(F)c(NCc2cccc(F)c2)n1.Fc1cccc(CNc2nc(F)ccc2F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.44
CLK4 Q9HAZ1 4/20 0.43
AURKA O14965 3/20 0.42
RPS6KB1 P23443 2/20 0.42
CCNE2 O96020 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
DAPK3 O43293 1/20 0.40
JAK2 O60674 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
PAK4 O96013 1/20 0.40
ABL1 P00519 1/20 0.40
LCK P06239 1/20 0.40
CSF1R P07333 1/20 0.40
RET P07949 1/20 0.40
PDGFRB P09619 1/20 0.40
FGFR1 P11362 1/20 0.40
PRKACA P17612 1/20 0.40
FLT1 P17948 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1192602 0.95 APP (0.47) APPCLK4AURKARPS6KB1CCNE2
SCHEMBL1192074 0.88 APP (0.52) APPCLK4AURKARPS6KB1CCNE2
SCHEMBL1224639 0.88 AURKA (0.43) APPCLK4AURKARPS6KB1CCNE2
SCHEMBL1192095 0.75 CCNE2 (0.47) APPCLK4AURKARPS6KB1CCNE2
SCHEMBL1191456 0.75 APP (0.50) APPCLK4AURKARPS6KB1CCNE2
SCHEMBL22792188 0.71 BRAF (0.53) CLK4PDGFRBDYRK1AADORA2AADORA2B
SCHEMBL16041322 0.70 APP (0.50) APPCLK4AURKARPS6KB1CCNE2
SCHEMBL27871448 0.69 CLK4 (0.51) APPCLK4AURKARPS6KB1CCNE2
SCHEMBL1192389 0.68 CCNT1 (0.58)
SCHEMBL1225589 0.67 APP (0.47) APPCLK4AURKARPS6KB1CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2668162-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES Novartis AG (CH) 2013-12-04 EP disclosed
WO-2012101065-A2 PYRIMIDINE BIARYL AMINE COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101062-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed